MedTrace Logo

The TRICURE EFS Study

NCT06506942 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-04-14

No results posted yet for this study

Summary

Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System

Conditions

Interventions

DEVICE

Transcatheter Tricuspid Valve Replacement

Replacement of the tricuspid valve through a transcatheter approach

Sponsors & Collaborators

  • TRiCares

    lead INDUSTRY

Principal Investigators

  • Susheel Kodali, MD · Columbia University Medical Center/ NewYork Presbyterian Hospital

  • Gorav Ailawadi, MD · University of Michigan Hospital and Health Systems

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-11
Primary Completion
2027-03-31
Completion
2031-03-31
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06506942 on ClinicalTrials.gov